Department of Development and Environmental Medicine, Fukushima Medical Center for Children and Women, Fukushima Medical University Graduate School of Medicine, Fukushima, Japan.
Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Miyagi, Japan.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):8919-8928. doi: 10.1080/14767058.2021.2007238. Epub 2021 Dec 2.
We evaluated the relationship between prenatal folic acid supplementation and autism spectrum disorder (ASD) in 3-year-old offspring.
We used data from the Japan Environment and Children's Study, a nationwide prospective birth cohort study. We analyzed the data to determine the association between folic acid supplement use and the incidence of ASD in offspring, and classified participants into three groups based on the time of initiation of folic acid supplementation, as follows: (1) preconception users of folic acid supplements and (2) post-conception users, and (3) non-users. The dietary folate intake of study participants was also classified into three groups (<200 µg, 200 µg to <400 µg, ≥400 µg).
Overall, 361 offspring of 96,931 participants with single pregnancies were diagnosed with ASD (0.37%). A total of 7,046 participants (7.3%) used folic acid supplements before conception, 29,984 (30.9%) took them after detection of pregnancy, and 59,901 (61.8%) never received them. Multivariate logistic regression analyses demonstrated no association between prenatal folic acid supplementation and ASD in offspring (preconception use: adjusted odds ratio [AOR], 1.189; 95% confidence interval [CI], 0.819-1.727 and post-conception use: AOR, 1.072; 95% CI, 0.840-1.368); additionally, no association was observed with the use of folic acid supplements and/or multivitamin supplements (preconception use: AOR, 1.273; 95% CI, 0.921-1.760 and post-conception use: AOR, 1.132; 95% CI, 0.885-1.449). Moreover, no significant association was observed in participants with combined prenatal supplement use and dietary folate intake.
Maternal use of folic acid supplements from the pre- or post-conception period was not significantly associated with ASD in 3-year-old offspring in Japan. Evaluation of the dietary folate intake from preconception also showed no significant association.
我们评估了产前叶酸补充与 3 岁儿童自闭症谱系障碍(ASD)之间的关系。
我们使用了日本环境与儿童研究的数据,这是一项全国性的前瞻性出生队列研究。我们分析了数据,以确定叶酸补充与后代 ASD 发病之间的关系,并根据叶酸补充的开始时间将参与者分为三组:(1)孕前叶酸补充者,(2)孕后叶酸补充者,和(3)非使用者。还将研究参与者的膳食叶酸摄入量分为三组(<200μg、200μg 至<400μg、≥400μg)。
共有 96931 名单胎妊娠参与者的 361 名子女被诊断为 ASD(0.37%)。共有 7046 名参与者(7.3%)在受孕前使用了叶酸补充剂,29984 名(30.9%)在检测到怀孕后使用,59901 名(61.8%)从未使用过。多变量逻辑回归分析表明,产前叶酸补充与儿童 ASD 之间没有关联(孕前使用:调整后的优势比 [AOR],1.189;95%置信区间 [CI],0.819-1.727;孕后使用:AOR,1.072;95%CI,0.840-1.368);此外,使用叶酸补充剂和/或多种维生素补充剂也没有关联(孕前使用:AOR,1.273;95%CI,0.921-1.760;孕后使用:AOR,1.132;95%CI,0.885-1.449)。此外,在联合使用产前补充剂和膳食叶酸摄入的参与者中,也没有观察到显著关联。
在日本,母亲在受孕前或受孕后使用叶酸补充剂与 3 岁儿童 ASD 之间没有显著关联。从受孕前评估膳食叶酸摄入量也没有显示出显著的关联。